Caribou Biosciences (CRBU) Times Interest Earned (2020 - 2021)
Caribou Biosciences (CRBU) reported Times Interest Earned of -$7982.0 for Q2 2021, down 1669.84% year-over-year from $508.46 in Q2 2020, and down 214.85% quarter-over-quarter from -$2535.2 in Q4 2020.
Caribou Biosciences (CRBU) Times Interest Earned (2020 - 2021) Analysis & Trends
Caribou Biosciences (CRBU) has 2 years of Times Interest Earned data on file, last reported at -$7982.0 in Q2 2021.
- Times Interest Earned for Q2 2021 came in at -$7982.0, down 1669.84% year-over-year; the trailing twelve-month figure through Mar 2022 was -$37919.0 (down 1558.41% YoY), and the FY2021 annual result was -$8372.4, down 363.54% from the prior year.
- Times Interest Earned eased to -$7982.0 in Q2 2021 per CRBU's latest filing, from -$2535.2 in the prior quarter.
- Over five years, Times Interest Earned peaked at -$451.0 in Q2 2020 and troughed at -$7982.0 in Q2 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 3.58 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 11.50 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -258.33 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 11.79 |
| 10 | Caribou Biosciences | 156.73 Mn | 39.11 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | -7,982.00 |
| Dec 31, 2020 | -2,535.17 |
| Sep 30, 2020 | -1,371.50 |
| Jun 30, 2020 | -451.00 |